Lessons for the US on Biosimilar Pricing
 â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â
Problems viewing this email?
View Message In Browser
<[link removed]>
Friday, December 9, 2022 | The Latest Research, Commentary, And News
From Health Affairs
Dear John,
This week, we announced a partnership agreement with Oxford University
Press (OUP) to publish Health Affairs Scholar, a new open access journal
of emerging and global health policy. Read more about the new journal
here.
<[link removed]>
Biosimilar Pricing
In a new Health Affairs article, James Robinson discusses lessons for
the US from Germany's therapeutic reference pricing for
anti-inflammatory biosimilars
<[link removed]>.
Robinson explains that the German experience demonstrates that a
redesign of consumer cost sharing that can achieve savings for payers
without creating onerous financial barriers for patients.
Savings would be achieved by shifting cost sharing from coinsurance to
"low copayments for affordable products and high copayments for
products bearing higher prices without offering superior performance,"
Robinson finds.
Robinson has published several articles about drug pricing and related
topics
<[link removed]>
which you can read on our website. He's also appeared on an episode of
<[link removed]>A
Health Podyssey
<[link removed]>Â Â to
discuss innovations in biosimilars.
Read More
<[link removed]>
[link removed]
Advertisement
Elsewhere At Health Affairs
Today on Forefront, LaCinda Jones and coauthors indicate that elder
mistreatment
<[link removed]>,
also referred to as elder abuse, is a major public health problem that
threatens the well-being of older adults and has been neglected and
underfunded.
Earlier this week, the Secretary of the Department of Health and Human
Services Xaiver Becerra and coauthors wrote an article about the
nation's behavioral health crisis
<[link removed]>
and the HHS roadmap to address it.
Enjoying Forefront <[link removed]> articles?
Bookmark our website to never miss an update.
[link removed]
Advertisement
[link removed]
Will Naloxone Become An Over-The-Counter Drug?
Listen to Leslie Erdelack and Jessica Bylander discuss the FDA's look
into the potential for over-the-counter naloxone products to help reduce
opioid overdose deaths.
Listen Here
<[link removed]>
Daily Digest
Germany's Use Of Reference Pricing For Biologics: Lessons For The US
<[link removed]>
James C. Robinson
To Confront Elder Mistreatment, Look To The VA's Social Work Response
<[link removed]>
LaCinda A. Jones et al.
[link removed]
[link removed]
Â
[link removed]
Â
[link removed]
Â
[link removed]
Â
mailto:
[email protected]
About Health Affairs
Health Affairs is the leading peer-reviewed journal
<[link removed]> at the intersection of health,
health care, and policy. Published monthly by Project HOPE, the journal
is available in print and online. Late-breaking content is also found
through healthaffairs.org <healthaffairs.org>, Health Affairs Today
<[link removed]>, and Health Affairs Sunday
Update <[link removed]>. Â
Project HOPE <[link removed]> is a global health and
humanitarian relief organization that places power in the hands of local
health care workers to save lives across the globe. Project HOPE has
published Health Affairs since 1981.
Copyright © Project HOPE: The People-to-People Health Foundation, Inc.
Health Affairs, 1220 19th Street, NW, Suite 800, Washington, DC 20036, United States
Privacy Policy <[link removed]>
To unsubscribe from this email, update your email preferences here
<[link removed]>.
_________________
Sent to
[email protected]
Unsubscribe:
[link removed]
Health Affairs, 1220 19th Street, NW, Suite 800, Washington, DC 20036, United States
